These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 7967940

  • 1. [Bacterial and clinical evaluation of axetil cefuroxime in suspension].
    Siwińska-Gołebiowska H, Szozda G, Pawluch D, Nowakowska K, Drejewicz H, Wawrzyniak M, Czerwińska I.
    Med Dosw Mikrobiol; 1994; 46(1-2):95-101. PubMed ID: 7967940
    [Abstract] [Full Text] [Related]

  • 2. [Susceptibility of bacteria to selected cephalosporins of the II and III generation].
    Nowakowska K, Szozda G, Pawluch D, Drejewicz H, Siwińska-Gołebiowska H.
    Med Dosw Mikrobiol; 1993; 45(2):177-82. PubMed ID: 8309293
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of in vitro activity of 4 oral beta-lactams on microorganisms responsible for broncho-pulmonary infections in children].
    Lambert-Zechovsky N, Mariani-Kurkdjian P, Bingen E, Lemer G, Sauzeau C.
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):738-41. PubMed ID: 3054759
    [Abstract] [Full Text] [Related]

  • 4. [Clinical results of cefuroxime (CXM) therapy in pediatric infections (author's transl)].
    Nakamura Y, Yanagisawa K, Ichihashi H.
    Jpn J Antibiot; 1979 Nov; 32(11):1132-6. PubMed ID: 390177
    [Abstract] [Full Text] [Related]

  • 5. [Detection of etiologic agents and antibiotic resistance in children with acute lower respiratory tract infection in Wenzhou City].
    Dong L, Zhou XC, Chen XF, Yang JH, Lin J, Zhang HL, Cai XH, Luo YC, Zhang ZX, Li CC.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):369-72. PubMed ID: 17052392
    [Abstract] [Full Text] [Related]

  • 6. [A clinical observation of cefuroxime in pediatric field (author's transl)].
    Ohnuma K, Asuka N, Aoyama R, Nagata K.
    Jpn J Antibiot; 1979 Nov; 32(11):1117-21. PubMed ID: 41955
    [Abstract] [Full Text] [Related]

  • 7. [Pathogenic bacteria of childhood lower respiratory tract infection].
    Hua CZ, Yu HM, Chen ZM, Li JP, Shang SQ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Oct; 8(5):365-8. PubMed ID: 17052391
    [Abstract] [Full Text] [Related]

  • 8. Susceptibility patterns of bacterial isolates from hospitalised patients with respiratory tract infections (MOXIAKTIV Study).
    Jacobs E, Dalhoff A, Korfmann G.
    Int J Antimicrob Agents; 2009 Jan; 33(1):52-7. PubMed ID: 18835763
    [Abstract] [Full Text] [Related]

  • 9. [Nosopharyngeal microflora in ambulatory treated children and adults with upper respiratory tract infections].
    Zientara M, Rudy M, Nowakowska M, Martirosian G.
    Med Dosw Mikrobiol; 2006 Jan; 58(3):239-45. PubMed ID: 17340999
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial therapy of upper respiratory tract infections in children.
    Tokarz A, Kozioł-Montewka M, Rutyna R, Chudnicka A, Sidor-Wójtowicz A.
    Ann Univ Mariae Curie Sklodowska Med; 2002 Jan; 57(2):119-26. PubMed ID: 12898829
    [Abstract] [Full Text] [Related]

  • 11. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of bacterial pneumonias with cefuroxime-axetil. Predictive value of measurement of the in vitro susceptibility].
    Cluzel R, Portier H, Modaï J.
    Pathol Biol (Paris); 1996 Mar; 44(3):217-23. PubMed ID: 8761613
    [Abstract] [Full Text] [Related]

  • 13. [In vitro comparative activity of moxifloxacin and other antimicrobials against respiratory pathogens].
    Prado V, Giangrieco M, Durán C, Ojeda A, van Flaskamp R.
    Rev Med Chil; 2000 Dec; 128(12):1319-26. PubMed ID: 11227240
    [Abstract] [Full Text] [Related]

  • 14. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
    Yüksel S, Oztürk B, Kavaz A, Ozçakar ZB, Acar B, Güriz H, Aysev D, Ekim M, Yalçinkaya F.
    Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
    [Abstract] [Full Text] [Related]

  • 15. Sputum bacteriology and its antibiotic susceptibilities in Turkish cystic fibrosis patients.
    Ozçelik U, Sener B, Göçmen A, Kiper N, Ergin A, Dilber E.
    Turk J Pediatr; 1996 Nov; 38(3):281-8. PubMed ID: 8827895
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Evaluation of sensitivity to antibiotics of microorganisms isolated from children with urinary tract infections].
    Cisowska A, Lewczyk E, Korzekwa K, Wojnicz D, Jankowski S, Doroszkiewicz W.
    Pol Merkur Lekarski; 2003 Apr; 14(82):322-6. PubMed ID: 12868193
    [Abstract] [Full Text] [Related]

  • 20. [Results of a clinical trial of the use of a methoxyamine (cefuroxime) in respiratory tract infections in children].
    Castello D, Sacchetti L, Brero P, Poncini L.
    Minerva Pediatr; 1981 Sep 15; 33(17):881-6. PubMed ID: 7031458
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.